Plasma levels of extracellular superoxide dismutase in an Australian population: Genetic contribution to normal variation and correlations with plasma nitric oxide and apolipoprotein A-I levels

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 3, 2000, Pages 683-688

  Mahaney, Michael C ^a   Czerwinski, Stefan A ^a   Adachi, Tetsuo ^b   Wilcken, David E L ^c   Wang, Xing Li ^c  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Apolipoproteins; Heritability; Nitric oxide; Pleiotropy; Superoxide dismutase

Indexed keywords

APOLIPOPROTEIN A1; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; GENETIC VARIABILITY; HERITABILITY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; PLEIOTROPY; PRIORITY JOURNAL;

EID: 0034099257     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.3.683     Document Type: Article

References (42)

1. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 1996:271:C1424-C1437.
2. Kroncke K-D, Fehsel K, Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection-how, why, when and where? Nitric Oxide. 1997; 1:107-120.
3. White CR, Brock TA, Chang L-Y, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci U S A. 1994;91: 1044-1048.
4. Squadrito GL, Pryor WA. The formation of peroxynitrite in vivo from nitric oxide and superoxide. Chem Biol Interact. 1995;96:203-206.
5. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical formation by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990;86:1620-1624.
6. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White RC. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994; 375:81-88.
7. Buttery LDK, Springall DR, Chester AH, Evans TJ, Standfield N, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77-85.
8. Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995;15: 2032-2036.
9. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A. 1982;79:7634-7638.
10. Weisiger RA, Fridovich I. Mitochondrial superoxide dismutase: site of synthesis and intramitochondrial localization. J Biol Chem. 1973;248: 4793-4896.
11. Karlsson K, Sandstrom J, Edlund A, Edlund T, Marklund SL. Pharmacokinetics of extracellular-superoxide dismutase in the vascular system. Free Radic Biol Med. 1993;14:185-190.
12. Karlsson K, Marklund SL. Extracellular superoxide dismutase in the vascular system of mammals. Biochem J. 1988;255:223-228.
13. Abrahamsson T, Brandt U, Marklund SL, Sjoqvist PO. Vascular bound recombinant extracellular superoxide dismutase type C protects against the detrimental effects of superoxide radicals on endolhelium-dependent arterial relaxation. Circ Res. 1992;70:264-271.
14. Karlsson K, Marklund SL. Extracellular superoxide dismutase association with cell surface-bound sulfated glucosaminoglycans. Basic Life Sci. 1988;49:647-650.
15. Sandstrom J, Karlsson K, Edlund T, Marklund SL. Heparin-affinity patterns and composition of extracellular-superoxide dismutase in human plasma and tissues. Biochem J. 1993;294:853-847.
16. Karlsson K, Marklund SL. Heparin-induced release of extracellular-superoxide dismutase to human blood plasma. Biochem J. 1987;242: 55-59.
17. Wang XL, Adachi T, Sim AS, Wilcken DEL. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:1915-1921.
18. Sandstrom J, Nilsson P, Karlsson K, Marklund SL. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem. 1994;269: 19163-19166.
19. Folz RJ, Crapo JD. Extracellular superoxide dismutase (SOD3): tissue-specific expression, genomic characterization, and computer-assisted sequence analysis of the human EC SOD gene. Genomics. 1994;22: 162-171.
20. Folz RJ, Peno-Green L, Crapo JD. Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of the human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels. Hum Mol Genet. 1994;3:2251-2254.
21. Yamada H, Yamada Y, Adachi T, Goto H, Ogasawara N, Futenma A, Kitano M, Hirano K, Kato K. Molecular analysis of extracellular-superoxide dismutase gene associated with high levels in serum. Jpn J Hum Genet. 1995;40:177-184.
22. Adachi T, Yamada H, Yamada Y, Morihara N, Yamazaki N, Murakami T, Futenma A, Kato K, Hirano K. Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface. Biochem J. 1996;313:235-239.
23. Karlsson K, Sandstrom J, Edlund A, Marklund SL. Turnover of extracellular-superoxide dismutase in tissues. Lab Invest. 1994;70: 705-710.
24. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, Almasy L, Badenhop RB, Wilcken DEL. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997;17:3147-3153.
25. Adachi T, Ohta H, Yamada H, Futenma A, Kato K, Hirano K. Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta. 1992;212:89-102.
26. Wang XL, Tam C, McCredie RM, Wilcken DEL. Determinants of severity of coronary artery disease in Australian men and women. Circulation. 1994;89:1974-1981.
27. Wang J, Brown MA, Tam SH, Chan MC, Whitworth JA Effects of diet on measurement of nitric oxide metabolites. Clin Exp Pharmacol Physiol. 1997;24:418-420.
28. Dyke B. PEDSYS: A Pedigree Data Management System. San Antonio, Tex: Population Genetics Laboratory, Southwest Foundation for Biomedical Research; 1998.
29. Almasy L, Blangero J. Multipoint quantitative linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
30. Hasstedt SJ. Pedigree Analysis Package, version 3.0. Salt Lake City, Utah: Department of Genetics, University of Utah; 1989.
31. Blangero J, Konigsberg LW. Multivariate segregation analysis using the mixed model. Genet Epidemiol. 1991;8:299-316.
32. Mahaney MC, Blangero J, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW. Plasma HDL cholesterol, triglycerides, and adiposity: a quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study. Circulation. 1995;92:3240-3248.
33. Edwards AWF. Likelihood. Cambridge,. UK: Cambridge University Press; 1972.
34. Elhadd TA, Khan F, Kirk G, McLaren M, Newton R, Greene SA, Belch JJF. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes. Diabetes Care. 1998;21: 1990-1996.
35. Luoma JS, Stralin P, Marklund SL, Hiltunen TP, Sarkioja T, Yla-Hertualla S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 1998;18: 157-167.
36. Comuzzie AG, Mahaney MC, Almasy L, Dyer TD, Blangero J. Exploiting pleiotropy to map genes for oligogenic phenotypes using extended pedigree data. Genet Epidemiol. 1997;14:975-980.
37. Czerwinski SA, Mahaney MC, Williams JT, Almasy L, Blangero J. Genetic analysis of personality traits and alcoholism using a mixed discrete continuous trait variance component model. Genet Epidemiol. 1999;17(Suppl 1):S121-S126.
38. Ott J, Rabinowitz D. A principal-components approach based on heritability for combining phenotype information. Hum Hered. 1999;49: 106-111.
39. Garner B, Wedlock R, Witting PK, Rye K-A, Stock R. Oxidation of high density lipoproteins, I: formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by α-tocopherol. J Biol Chem. 1998;273: 6080-6087.
40. Gamer B, Waldeck R, Witting PK, Rye K-A, Stock R. Oxidation of high density lipoproteins, I: evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoprotein AI and AII. J Biol Chem. 1998;273:6088-6095.
41. Wang W-Q, Merriam DL, Moses AS, Francis GA. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J Biol Chem. 1998;273: 17391-17398.
42. Rudic RD, Sessa WC. Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links. Am J Hum Genet. 1999;64:673-677.